These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 36275477)
1. Signal peptidase 21 suppresses cell proliferation, migration, and invasion via the PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Zhang N; Cao S; Sun R; Wang Y; Liu L; Wang W; Meng X PeerJ; 2022; 10():e14206. PubMed ID: 36275477 [TBL] [Abstract][Full Text] [Related]
3. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway. Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942 [TBL] [Abstract][Full Text] [Related]
4. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1. Xu T; Yin F; Shi K Exp Cell Res; 2024 Apr; 437(1):114010. PubMed ID: 38508329 [TBL] [Abstract][Full Text] [Related]
5. Cyanidin-3-glucoside suppresses the progression of lung adenocarcinoma by downregulating TP53I3 and inhibiting PI3K/AKT/mTOR pathway. Chen X; Zhang W; Xu X World J Surg Oncol; 2021 Aug; 19(1):232. PubMed ID: 34362378 [TBL] [Abstract][Full Text] [Related]
6. GALNT2 promotes cell proliferation, migration, and invasion by activating the Notch/Hes1-PTEN-PI3K/Akt signaling pathway in lung adenocarcinoma. Wang W; Sun R; Zeng L; Chen Y; Zhang N; Cao S; Deng S; Meng X; Yang S Life Sci; 2021 Jul; 276():119439. PubMed ID: 33785338 [TBL] [Abstract][Full Text] [Related]
7. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway. Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133 [TBL] [Abstract][Full Text] [Related]
8. TM6SF1 suppresses the progression of lung adenocarcinoma and M2 macrophage polarization by inactivating the PI3K/AKT/mtor pathway. Huang S; Zhao H; Lou X; Chen D; Shi C; Ren Z Biochem Biophys Res Commun; 2024 Jul; 718():149983. PubMed ID: 38718735 [TBL] [Abstract][Full Text] [Related]
9. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN. Feng H; Zhang Z; Qing X; French SW; Liu D Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721 [TBL] [Abstract][Full Text] [Related]
10. Junctional adhesion molecule-like protein as a novel target for kaempferol to ameliorate lung adenocarcinoma. Wu Q; Wang YB; Che XW; Wang H; Wang W J Integr Med; 2023 May; 21(3):268-276. PubMed ID: 37069006 [TBL] [Abstract][Full Text] [Related]
11. CD73 (NT5E) Promotes the Proliferation and Metastasis of Lung Adenocarcinoma through the EGFR/AKT/mTOR Pathway. Zhang H; Cao Y; Tang J; Wang R Biomed Res Int; 2022; 2022():9944847. PubMed ID: 35813221 [TBL] [Abstract][Full Text] [Related]
12. C1orf74 positively regulates the EGFR/AKT/mTORC1 signaling in lung adenocarcinoma cells. Guo J; Li A; Guo R; He Q; Wu Y; Gou Y; Jin J; Huang G PeerJ; 2022; 10():e13908. PubMed ID: 36032960 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-126 Targeting PIK3R2 Inhibits NSCLC A549 Cell Proliferation, Migration, and Invasion by Regulation of PTEN/PI3K/AKT Pathway. Song L; Li D; Gu Y; Wen ZM; Jie J; Zhao D; Peng LP Clin Lung Cancer; 2016 Sep; 17(5):e65-e75. PubMed ID: 27236384 [TBL] [Abstract][Full Text] [Related]
14. Oncogenic zinc finger protein ZNF687 accelerates lung adenocarcinoma cell proliferation and tumor progression by activating the PI3K/AKT signaling pathway. Li M; Liu Z; Hou Z; Wang X; Shi H; Li Y; Xiao X; Tang Z; Yang J; Luo Y; Zhang M; Chen M Thorac Cancer; 2023 May; 14(14):1223-1238. PubMed ID: 36944484 [TBL] [Abstract][Full Text] [Related]
15. DUS4L suppresses invasion and metastasis in LUAD via modulation of PI3K/AKT and ERK/MAPK signaling through GRB2. Li Z; Zhao PL; Gao X; Li X; Meng YQ; Li ZQ; Zhai KR; Wei SL; Feng HM; Huang HR; Li B Int Immunopharmacol; 2024 Dec; 142(Pt A):113043. PubMed ID: 39216120 [TBL] [Abstract][Full Text] [Related]
16. COL3A1-positive endothelial cells influence LUAD prognosis and regulate LUAD carcinogenesis by NCL-PI3K-AKT axis. Zhang M; Liang Y; Song P J Gene Med; 2024 Jan; 26(1):e3573. PubMed ID: 37547956 [TBL] [Abstract][Full Text] [Related]
17. Mex3a interacts with LAMA2 to promote lung adenocarcinoma metastasis via PI3K/AKT pathway. Liang J; Li H; Han J; Jiang J; Wang J; Li Y; Feng Z; Zhao R; Sun Z; Lv B; Tian H Cell Death Dis; 2020 Aug; 11(8):614. PubMed ID: 32792503 [TBL] [Abstract][Full Text] [Related]
18. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway. Zhu HE; Yin JY; Chen DX; He S; Chen H Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997 [TBL] [Abstract][Full Text] [Related]
19. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis. Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515 [TBL] [Abstract][Full Text] [Related]
20. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway. Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]